Physiotherapy and Dysfunctional Breathing

Hyperventilation Clinical Trial

— HVS  

Official title:

A Comparison of the Effects of Respiratory Physiotherapy Alone and Respiratory Physiotherapy Combined With Musculoskeletal Techniques in the Management of Dysfunctional Breathing

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT00895219
• Other study ID #: 06/Q0404/64
• Status: Active, not recruiting
• Phase: Phase 3
• First received: May 7, 2009
• Last updated: May 7, 2009
• Start date: July 2007
• Est. completion date: December 2009

Study information

• Verified date: April 2009
• Source: Royal Brompton & Harefield NHS Foundation Trust
• Contact: n/a
• Is FDA regulated: No
• Health authority: United Kingdom: National Health Service
• Study type: Interventional

Clinical Trial Summary

Traditionally, the physiotherapy management of people with dysfunctional breathing or hyperventilation syndrome is breathing re-training. There is increasing clinical evidence that structural and functional changes develop in the muscles and connective tissues of the chest wall, abdomen and back when the upper chest accessory pattern of breathing is used over time. When treatment includes breathing techniques only it is difficult for a person with chronic hyperventilation, who has developed muscle and connective tissue changes, to revert to using the normal lower chest diaphragmatic breathing pattern. In clinical practice when the problems which have developed in the musculoskeletal system are addressed, the patient reverts more quickly to the lower chest pattern of breathing but there is as yet little evidence to support this clinical finding.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 60
• Est. completion date: December 2009
• Est. primary completion date: July 2009
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 16 Years and older

Eligibility

Inclusion Criteria:

• diagnosis of dysfunctional breathing (Nijmegen score of more than 23)

Exclusion Criteria:

• active metastatic disease

• osteoporotic disease

• dysfunctional breathing as a consequence of respiratory or cardiac disease

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Hyperventilation

Intervention

Other:
• Breathing re-training
Breathing re-training
• Breathing re-training and musculoskeletal techniques
Breathing re-training and musculoskeletal physiotherapy techniques including mobilisation techniques to normalise muscle and joint restrictions, doming of the diaphragm to enhance contraction and relaxation, and rib raising to free restriction in rib cage motion.

Locations

Country	Name	City	State
United Kingdom	Royal Brompton Hospital	London

Sponsors (1)

Lead Sponsor	Collaborator
Royal Brompton & Harefield NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Nijmegen Questionnaire		0, 2, 4, 8, 12 and 26 weeks	No
Secondary	Six-minute walking test		0, 2, 4, 8, 12 & 26 weeks	No